Semaglutide activates glucagon-like-peptide-1 receptors in the brain, regulating appetite and caloric intake. Essentially decreasing the brain’s interpretation of food as a reward. On average, research shows a total body weight loss of 5-15% in 3-6 months. Our medically supervised weight loss program will reduce appetite, cravings, caloric intake and boost energy!